Compare Bath & Body Works Inc (BBWI) vs BioNano Genomics Inc (BNGO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs BioNano Genomics Inc — how do they compare? Bath & Body Works Inc trades at $19 (market cap $3.81B), while BioNano Genomics Inc trades at $1.19 (market cap $13.66M). The key difference: Bath & Body Works Inc is far larger — about 278.9× BioNano Genomics Inc's market cap, and Bath & Body Works Inc pays a 4.24% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BBWI | BNGO | |
|---|---|---|
Market Cap | $3.81B | $13.66M |
Sector | Consumer Cyclical | Health |
52-Week High | $31.87 | $4.92 |
52-Week Low | $14.85 | $1.06 |
Enterprise Value | $7.70B | $16.26M |
Dividend Yield | 4.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →
